Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
University of Texas Southwestern, Department of Neurology and Neurotherapeutics, Dallas, TX, USA.
Mark J
MJ
Alberts
Baylor College of Medicine, Department of Emergency Medicine, Houston, TX, USA.
W Frank
WF
Peacock
Janssen Scientific Affairs, LLC, Raritan, NJ, USA.
Larry E
LE
Fields
University of Connecticut, School of Pharmacy, Storrs, CT, USA.
Thomas J
TJ
Bunz
University of Connecticut, School of Pharmacy, Storrs, CT, USA; Hartford Hospital Evidence-Based Practice Center, Hartford, CT, USA.
Elaine
E
Nguyen
Janssen Scientific Affairs, LLC, Raritan, NJ, USA.
Dejan
D
Milentijevic
Janssen Scientific Affairs, LLC, Raritan, NJ, USA.
Jeff R
JR
Schein
University of Connecticut, School of Pharmacy, Storrs, CT, USA; Hartford Hospital Evidence-Based Practice Center, Hartford, CT, USA. Electronic address: craig.coleman@hhchealth.org.
Craig I
CI
Coleman
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000453:epidemiology; D004334:Drug Administration Schedule; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D008297:Male; D006278:Medicare; D008875:Middle Aged; D057216:Propensity Score; D020521:Stroke / Q000453:epidemiology* / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D055815:Young Adult; D016903:Drug Monitoring
D000925:Anticoagulants
Anticoagulation; Direct oral anticoagulant; Medication adherence; Nonvalvular atrial fibrillation; Proportion of days covered